Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome

Clinical use of antibiotics is based on their capacity to inhibit bacterial growth via bacteriostatic or bacteriocidal effects. In this article, we show that the aminoglycoside antibiotic neomycin, the cyclic lipopeptide antibiotic polymyxin B, and the cyclic peptide antibiotics gramicidin and tyrot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 2011-03, Vol.186 (5), p.2714-2718
Hauptverfasser: Allam, Ramanjaneyulu, Darisipudi, Murthy Narayana, Rupanagudi, Khader Valli, Lichtnekert, Julia, Tschopp, Jurg, Anders, Hans-Joachim
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2718
container_issue 5
container_start_page 2714
container_title The Journal of immunology (1950)
container_volume 186
creator Allam, Ramanjaneyulu
Darisipudi, Murthy Narayana
Rupanagudi, Khader Valli
Lichtnekert, Julia
Tschopp, Jurg
Anders, Hans-Joachim
description Clinical use of antibiotics is based on their capacity to inhibit bacterial growth via bacteriostatic or bacteriocidal effects. In this article, we show that the aminoglycoside antibiotic neomycin, the cyclic lipopeptide antibiotic polymyxin B, and the cyclic peptide antibiotics gramicidin and tyrothricin can induce IL-1β secretion in bone marrow dendritic cells and macrophages. LPS priming was required to trigger the transcription and translation of pro-IL-1β but was independent of TNFR or IL-1R signaling. All four antibiotics required the NLRP3 inflammasome, the adaptor ASC, and caspase-1 activation to secrete IL-1β, a process that depended on potassium efflux but was independent of P2X7 receptor. All four antibiotics induced neutrophil influx into the peritoneal cavity of mice, which required NLRP3 only in the case of polymyxin B. Together, certain antibiotics have the potential to directly activate innate immunity of the host.
doi_str_mv 10.4049/jimmunol.1002657
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_907154461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>852904934</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-aeb515e2388b37a87af5c4fb267d283bc149a457e678d54998a002a2365912143</originalsourceid><addsrcrecordid>eNqFkc1O3DAURq2qqEyH7rtC3nWVqf-dsKtG0CKNCkKwjhznJhjFcYidSlnwUjwIz9TQGbpldaVP9zvSvQehr5RsBBHF9wfn_dSHbkMJYUrqD2hFpSSZUkR9RKslZBnVSh-jzzE-EEIUYeITOmaU6ZwLsUJP2ykl17cY6hbOsJ1t5yweQjcPMCRXAzZ9jY13fWi72Ya4j5KrXEjORpxG17Yw4stdRl-ecQQ7QnKhx9WMjU3uj_mHT_eAf-9urjl2fdMZ700MHk7QUWO6CF8Oc43uLs5vt7-y3dXPy-2PXWa5ZikzUEkqgfE8r7g2uTaNtKKpmNI1y3llqSiMkBqUzmspiiI3y-mGcSULyqjga_Rtzx3G8DhBTKV30ULXmR7CFMuCaCqFUPTdzVyyYvk8f2WS_aYdQ4wjNOUwOm_GuaSkfLVTvtkpD3aWyukBPlUe6v-FNx38L8InjlE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>852904934</pqid></control><display><type>article</type><title>Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Allam, Ramanjaneyulu ; Darisipudi, Murthy Narayana ; Rupanagudi, Khader Valli ; Lichtnekert, Julia ; Tschopp, Jurg ; Anders, Hans-Joachim</creator><creatorcontrib>Allam, Ramanjaneyulu ; Darisipudi, Murthy Narayana ; Rupanagudi, Khader Valli ; Lichtnekert, Julia ; Tschopp, Jurg ; Anders, Hans-Joachim</creatorcontrib><description>Clinical use of antibiotics is based on their capacity to inhibit bacterial growth via bacteriostatic or bacteriocidal effects. In this article, we show that the aminoglycoside antibiotic neomycin, the cyclic lipopeptide antibiotic polymyxin B, and the cyclic peptide antibiotics gramicidin and tyrothricin can induce IL-1β secretion in bone marrow dendritic cells and macrophages. LPS priming was required to trigger the transcription and translation of pro-IL-1β but was independent of TNFR or IL-1R signaling. All four antibiotics required the NLRP3 inflammasome, the adaptor ASC, and caspase-1 activation to secrete IL-1β, a process that depended on potassium efflux but was independent of P2X7 receptor. All four antibiotics induced neutrophil influx into the peritoneal cavity of mice, which required NLRP3 only in the case of polymyxin B. Together, certain antibiotics have the potential to directly activate innate immunity of the host.</description><identifier>ISSN: 0022-1767</identifier><identifier>EISSN: 1550-6606</identifier><identifier>DOI: 10.4049/jimmunol.1002657</identifier><identifier>PMID: 21278344</identifier><language>eng</language><publisher>United States</publisher><subject>Aminoglycosides - pharmacology ; Animals ; Anti-Bacterial Agents - pharmacology ; Bone Marrow Cells - drug effects ; Bone Marrow Cells - immunology ; Bone Marrow Cells - pathology ; Carrier Proteins - genetics ; Carrier Proteins - metabolism ; Dendritic Cells - immunology ; Dendritic Cells - metabolism ; Dendritic Cells - pathology ; Humans ; Inflammasomes - genetics ; Inflammasomes - metabolism ; Inflammasomes - physiology ; Interleukin-1beta - biosynthesis ; Interleukin-1beta - secretion ; Macrophage Activation - drug effects ; Macrophage Activation - immunology ; Macrophages, Peritoneal - immunology ; Macrophages, Peritoneal - metabolism ; Macrophages, Peritoneal - pathology ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; NLR Family, Pyrin Domain-Containing 3 Protein ; Peptides, Cyclic - pharmacology ; Peritonitis - immunology ; Peritonitis - metabolism ; Peritonitis - pathology ; Protein Precursors - biosynthesis ; Protein Precursors - secretion ; Receptors, Interleukin-1 - deficiency ; Receptors, Interleukin-1 - genetics</subject><ispartof>The Journal of immunology (1950), 2011-03, Vol.186 (5), p.2714-2718</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-aeb515e2388b37a87af5c4fb267d283bc149a457e678d54998a002a2365912143</citedby><cites>FETCH-LOGICAL-c372t-aeb515e2388b37a87af5c4fb267d283bc149a457e678d54998a002a2365912143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21278344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Allam, Ramanjaneyulu</creatorcontrib><creatorcontrib>Darisipudi, Murthy Narayana</creatorcontrib><creatorcontrib>Rupanagudi, Khader Valli</creatorcontrib><creatorcontrib>Lichtnekert, Julia</creatorcontrib><creatorcontrib>Tschopp, Jurg</creatorcontrib><creatorcontrib>Anders, Hans-Joachim</creatorcontrib><title>Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome</title><title>The Journal of immunology (1950)</title><addtitle>J Immunol</addtitle><description>Clinical use of antibiotics is based on their capacity to inhibit bacterial growth via bacteriostatic or bacteriocidal effects. In this article, we show that the aminoglycoside antibiotic neomycin, the cyclic lipopeptide antibiotic polymyxin B, and the cyclic peptide antibiotics gramicidin and tyrothricin can induce IL-1β secretion in bone marrow dendritic cells and macrophages. LPS priming was required to trigger the transcription and translation of pro-IL-1β but was independent of TNFR or IL-1R signaling. All four antibiotics required the NLRP3 inflammasome, the adaptor ASC, and caspase-1 activation to secrete IL-1β, a process that depended on potassium efflux but was independent of P2X7 receptor. All four antibiotics induced neutrophil influx into the peritoneal cavity of mice, which required NLRP3 only in the case of polymyxin B. Together, certain antibiotics have the potential to directly activate innate immunity of the host.</description><subject>Aminoglycosides - pharmacology</subject><subject>Animals</subject><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Bone Marrow Cells - drug effects</subject><subject>Bone Marrow Cells - immunology</subject><subject>Bone Marrow Cells - pathology</subject><subject>Carrier Proteins - genetics</subject><subject>Carrier Proteins - metabolism</subject><subject>Dendritic Cells - immunology</subject><subject>Dendritic Cells - metabolism</subject><subject>Dendritic Cells - pathology</subject><subject>Humans</subject><subject>Inflammasomes - genetics</subject><subject>Inflammasomes - metabolism</subject><subject>Inflammasomes - physiology</subject><subject>Interleukin-1beta - biosynthesis</subject><subject>Interleukin-1beta - secretion</subject><subject>Macrophage Activation - drug effects</subject><subject>Macrophage Activation - immunology</subject><subject>Macrophages, Peritoneal - immunology</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Macrophages, Peritoneal - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>NLR Family, Pyrin Domain-Containing 3 Protein</subject><subject>Peptides, Cyclic - pharmacology</subject><subject>Peritonitis - immunology</subject><subject>Peritonitis - metabolism</subject><subject>Peritonitis - pathology</subject><subject>Protein Precursors - biosynthesis</subject><subject>Protein Precursors - secretion</subject><subject>Receptors, Interleukin-1 - deficiency</subject><subject>Receptors, Interleukin-1 - genetics</subject><issn>0022-1767</issn><issn>1550-6606</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1O3DAURq2qqEyH7rtC3nWVqf-dsKtG0CKNCkKwjhznJhjFcYidSlnwUjwIz9TQGbpldaVP9zvSvQehr5RsBBHF9wfn_dSHbkMJYUrqD2hFpSSZUkR9RKslZBnVSh-jzzE-EEIUYeITOmaU6ZwLsUJP2ykl17cY6hbOsJ1t5yweQjcPMCRXAzZ9jY13fWi72Ya4j5KrXEjORpxG17Yw4stdRl-ecQQ7QnKhx9WMjU3uj_mHT_eAf-9urjl2fdMZ700MHk7QUWO6CF8Oc43uLs5vt7-y3dXPy-2PXWa5ZikzUEkqgfE8r7g2uTaNtKKpmNI1y3llqSiMkBqUzmspiiI3y-mGcSULyqjga_Rtzx3G8DhBTKV30ULXmR7CFMuCaCqFUPTdzVyyYvk8f2WS_aYdQ4wjNOUwOm_GuaSkfLVTvtkpD3aWyukBPlUe6v-FNx38L8InjlE</recordid><startdate>20110301</startdate><enddate>20110301</enddate><creator>Allam, Ramanjaneyulu</creator><creator>Darisipudi, Murthy Narayana</creator><creator>Rupanagudi, Khader Valli</creator><creator>Lichtnekert, Julia</creator><creator>Tschopp, Jurg</creator><creator>Anders, Hans-Joachim</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20110301</creationdate><title>Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome</title><author>Allam, Ramanjaneyulu ; Darisipudi, Murthy Narayana ; Rupanagudi, Khader Valli ; Lichtnekert, Julia ; Tschopp, Jurg ; Anders, Hans-Joachim</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-aeb515e2388b37a87af5c4fb267d283bc149a457e678d54998a002a2365912143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Aminoglycosides - pharmacology</topic><topic>Animals</topic><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Bone Marrow Cells - drug effects</topic><topic>Bone Marrow Cells - immunology</topic><topic>Bone Marrow Cells - pathology</topic><topic>Carrier Proteins - genetics</topic><topic>Carrier Proteins - metabolism</topic><topic>Dendritic Cells - immunology</topic><topic>Dendritic Cells - metabolism</topic><topic>Dendritic Cells - pathology</topic><topic>Humans</topic><topic>Inflammasomes - genetics</topic><topic>Inflammasomes - metabolism</topic><topic>Inflammasomes - physiology</topic><topic>Interleukin-1beta - biosynthesis</topic><topic>Interleukin-1beta - secretion</topic><topic>Macrophage Activation - drug effects</topic><topic>Macrophage Activation - immunology</topic><topic>Macrophages, Peritoneal - immunology</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Macrophages, Peritoneal - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>NLR Family, Pyrin Domain-Containing 3 Protein</topic><topic>Peptides, Cyclic - pharmacology</topic><topic>Peritonitis - immunology</topic><topic>Peritonitis - metabolism</topic><topic>Peritonitis - pathology</topic><topic>Protein Precursors - biosynthesis</topic><topic>Protein Precursors - secretion</topic><topic>Receptors, Interleukin-1 - deficiency</topic><topic>Receptors, Interleukin-1 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Allam, Ramanjaneyulu</creatorcontrib><creatorcontrib>Darisipudi, Murthy Narayana</creatorcontrib><creatorcontrib>Rupanagudi, Khader Valli</creatorcontrib><creatorcontrib>Lichtnekert, Julia</creatorcontrib><creatorcontrib>Tschopp, Jurg</creatorcontrib><creatorcontrib>Anders, Hans-Joachim</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of immunology (1950)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Allam, Ramanjaneyulu</au><au>Darisipudi, Murthy Narayana</au><au>Rupanagudi, Khader Valli</au><au>Lichtnekert, Julia</au><au>Tschopp, Jurg</au><au>Anders, Hans-Joachim</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome</atitle><jtitle>The Journal of immunology (1950)</jtitle><addtitle>J Immunol</addtitle><date>2011-03-01</date><risdate>2011</risdate><volume>186</volume><issue>5</issue><spage>2714</spage><epage>2718</epage><pages>2714-2718</pages><issn>0022-1767</issn><eissn>1550-6606</eissn><abstract>Clinical use of antibiotics is based on their capacity to inhibit bacterial growth via bacteriostatic or bacteriocidal effects. In this article, we show that the aminoglycoside antibiotic neomycin, the cyclic lipopeptide antibiotic polymyxin B, and the cyclic peptide antibiotics gramicidin and tyrothricin can induce IL-1β secretion in bone marrow dendritic cells and macrophages. LPS priming was required to trigger the transcription and translation of pro-IL-1β but was independent of TNFR or IL-1R signaling. All four antibiotics required the NLRP3 inflammasome, the adaptor ASC, and caspase-1 activation to secrete IL-1β, a process that depended on potassium efflux but was independent of P2X7 receptor. All four antibiotics induced neutrophil influx into the peritoneal cavity of mice, which required NLRP3 only in the case of polymyxin B. Together, certain antibiotics have the potential to directly activate innate immunity of the host.</abstract><cop>United States</cop><pmid>21278344</pmid><doi>10.4049/jimmunol.1002657</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-1767
ispartof The Journal of immunology (1950), 2011-03, Vol.186 (5), p.2714-2718
issn 0022-1767
1550-6606
language eng
recordid cdi_proquest_miscellaneous_907154461
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Aminoglycosides - pharmacology
Animals
Anti-Bacterial Agents - pharmacology
Bone Marrow Cells - drug effects
Bone Marrow Cells - immunology
Bone Marrow Cells - pathology
Carrier Proteins - genetics
Carrier Proteins - metabolism
Dendritic Cells - immunology
Dendritic Cells - metabolism
Dendritic Cells - pathology
Humans
Inflammasomes - genetics
Inflammasomes - metabolism
Inflammasomes - physiology
Interleukin-1beta - biosynthesis
Interleukin-1beta - secretion
Macrophage Activation - drug effects
Macrophage Activation - immunology
Macrophages, Peritoneal - immunology
Macrophages, Peritoneal - metabolism
Macrophages, Peritoneal - pathology
Mice
Mice, Inbred C57BL
Mice, Knockout
NLR Family, Pyrin Domain-Containing 3 Protein
Peptides, Cyclic - pharmacology
Peritonitis - immunology
Peritonitis - metabolism
Peritonitis - pathology
Protein Precursors - biosynthesis
Protein Precursors - secretion
Receptors, Interleukin-1 - deficiency
Receptors, Interleukin-1 - genetics
title Cutting edge: cyclic polypeptide and aminoglycoside antibiotics trigger IL-1β secretion by activating the NLRP3 inflammasome
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T23%3A16%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cutting%20edge:%20cyclic%20polypeptide%20and%20aminoglycoside%20antibiotics%20trigger%20IL-1%CE%B2%20secretion%20by%20activating%20the%20NLRP3%20inflammasome&rft.jtitle=The%20Journal%20of%20immunology%20(1950)&rft.au=Allam,%20Ramanjaneyulu&rft.date=2011-03-01&rft.volume=186&rft.issue=5&rft.spage=2714&rft.epage=2718&rft.pages=2714-2718&rft.issn=0022-1767&rft.eissn=1550-6606&rft_id=info:doi/10.4049/jimmunol.1002657&rft_dat=%3Cproquest_cross%3E852904934%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=852904934&rft_id=info:pmid/21278344&rfr_iscdi=true